Najoh Tita-Reid - Nov 6, 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Nov 6, 2024
Transactions value $
$0
Form type
4
Date filed
11/8/2024, 04:27 PM
Previous filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +24.9K +107.05% $0.00 48.2K Nov 6, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +49.9K $0.00 49.9K Nov 6, 2024 Common Stock 49.9K $0.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units for common stock vest 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.
F2 This option vests 100% on the earlier of November 6, 2025 or the date of the next annual meeting of stockholders.